Related Experiment Video
Updated: Jun 24, 2025

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Drug-Induced Liver Injury Due to Doxycycline: A Case Report and Review of Literature
Nikola Nikolajevic1, Milan Nikolajevic1, Ivana Pantic2
1Internal Medicine, University of Belgrade, Faculty of Medicine, Belgrade, SRB.
Abstract:
Antibiotics are among the most common causes of drug-induced liver injury worldwide. Amoxicillin/clavulanic acid and nitrofurantoin are the most common culprits while tetracyclines are a rare cause of liver injury. Among tetracyclines, minocycline has been reported more frequently than doxycycline, which is an extremely rare cause of drug-induced liver injury. We present a healthy 28-year-old male patient from rural United States who was taking doxycycline for Lyme disease. After five days of therapy, he developed nausea, vomiting, fatigue, and significant transaminitis consistent with a hepatocellular pattern of liver injury. After a thorough workup which ruled out other causes such as infection, autoimmune diseases, liver malignancy, and vascular, structural, and metabolic disorders, his liver injury was attributed to doxycycline. We reached the diagnosis also by demonstrating a consistent temporal association between doxycycline intake and liver injury and the patient recovered completely with the cessation of doxycycline. Recognition of doxycycline as a cause of drug-induced liver injury should be considered in patients utilizing this antibiotic. Doxycycline, unlike minocycline, has a short latency period. Early recognition and discontinuation of doxycycline in our patient resulted in the complete resolution of symptoms and transaminitis preventing further morbidity and mortality.
Insights
Doxycycline, an antibiotic, can rarely cause drug-induced liver injury (DILI) presenting as hepatocellular damage. Early recognition and discontinuation of doxycycline led to complete recovery in a patient with Lyme disease.
Area of Science:
- Hepatology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotics are a leading cause of drug-induced liver injury (DILI) globally.
- While amoxicillin/clavulanic acid and nitrofurantoin are common causes, tetracyclines are rare offenders.
- Minocycline is more frequently implicated in DILI than doxycycline among tetracyclines.
Observation:
- A healthy 28-year-old male developed acute liver injury with a hepatocellular pattern five days after starting doxycycline for Lyme disease.
- Symptoms included nausea, vomiting, fatigue, and elevated transaminases.
- Exclusion of other potential causes like infections, autoimmune disorders, and malignancies was performed.
Findings:
- Doxycycline was identified as the causative agent for the patient's liver injury.
- Diagnosis was supported by the temporal relationship between doxycycline intake and symptom onset.
- Complete resolution of liver injury occurred upon cessation of doxycycline.
Implications:
- Doxycycline should be recognized as a potential cause of drug-induced liver injury.
- Unlike minocycline, doxycycline exhibits a shorter latency period for DILI.
- Prompt diagnosis and withdrawal of doxycycline can prevent severe liver damage and ensure patient recovery.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Drug Distribution: Tissue Binding
For...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

